Bausch & Lomb Corp (BLCO) Form 10-Q — Oct 28, 2026
Bausch + Lomb returned to quarterly profitability in Q3 2026, posting $1,375 million in revenue (up ~7% YoY) and $32 million of net income attributable to shareholders versus a $28 million loss a year earlier, with operating income rising to $155 million from $95 million. The nine-month picture remains modestly negative (a $53 million attributable loss, $0.15 per share), but operating cash flow improved sharply to $418 million from $147 million, and cash rose to $513 million.
Key figures
- Eps
- 0.09
- Revenue
- 4013000000
- Net Income
- Q3 attributable net income $32M vs. loss of $28M in Q3 2025; nine-month attributable loss $53M
- Total Debt
- 5065000000
- Revenue Yoy
- Q3: +7.3% ($1,375M vs $1,281M); nine months: $4,013M vs $3,696M
- Total Assets
- 13959000000
- Cash Position
- 513000000
- Shares Outstanding
- 357497374
- Goodwill
- 4714000000
- Bhc shares held
- 310449643
- Operating income q3
- 155000000
- Bhc ownership percent
- approximately 87%
- Revolver availability
- 666000000
- Operating income q3 prior
- 95000000
- Weighted avg interest rate
- 7.63%
- Pending acquisition upfront
- $85 million (ophthalmic surgical manufacturing businesses, expected Q4 2026 close)
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.